Table 4 Frequency of biomarkers appearing in the top 2, 3, 4, and 5 biomarkers with highest area under the ROC curve (AUC) across 10 imputed datasets
From: Evaluation of protein biomarkers of prostate cancer aggressiveness
Variable | Top 2 | Top 3 | Top 4 | Top 5 |
|---|---|---|---|---|
ACPP | 0 | 0 | 0 | 0 |
ADAM9 | 0 | 0 | 0 | 0 |
ALDH1A2 | 0 | 0 | 0 | 0 |
CASR | 0 | 0 | 0 | 0 |
CCND1 (nuclear) | 0 | 0 | 0 | 0 |
CCPG1 | 0 | 0 | 0 | 0 |
CD34 (avg vess area) | 0 | 0 | 0 | 0 |
CD34 (avg vess per) | 0 | 1 | 4 | 5 |
CD34 (avg lum area) | 0 | 1 | 3 | 3 |
CD34 (avg vasc area) | 0 | 0 | 0 | 0 |
CD34 (MVD) | 0 | 0 | 0 | 0 |
CD34 | 0 | 0 | 0 | 0 |
CD44 | 0 | 0 | 0 | 0 |
CD44v6 | 0 | 2 | 2 | 2 |
CHGA | 0 | 1 | 1 | 2 |
CHMP1A | 0 | 0 | 0 | 0 |
EI24 (stroma) | 0 | 0 | 0 | 0 |
EI24 (tumor) | 0 | 0 | 0 | 0 |
ENO2 | 0 | 0 | 1 | 1 |
GADD45B | 0 | 0 | 0 | 0 |
HA (stroma) | 1 | 1 | 1 | 3 |
HAS2 | 0 | 0 | 0 | 0 |
HES6 | 0 | 0 | 0 | 0 |
HMMR | 2 | 4 | 6 | 6 |
HOXC6 | 0 | 0 | 0 | 0 |
HYAL1 | 0 | 0 | 0 | 0 |
IGF1 | 0 | 0 | 0 | 0 |
IQCK | 0 | 0 | 0 | 0 |
MAP4K4 | 0 | 0 | 0 | 0 |
MKI67 (nuclear) | 0 | 0 | 0 | 0 |
PAGE4 | 0 | 0 | 0 | 0 |
PLIN2 | 0 | 0 | 0 | 0 |
PTEN | 0 | 0 | 0 | 0 |
SIAH2 (nuclear) | 7 | 10 | 10 | 10 |
SMAD4 | 4 | 7 | 7 | 8 |
SOX9 | 0 | 0 | 0 | 0 |
SPP1 | 0 | 0 | 0 | 0 |
SYP | 0 | 0 | 0 | 0 |
TP53_Lab1 (nuclear) | 0 | 0 | 0 | 0 |
TP53_Lab2 (nuclear) | 0 | 0 | 0 | 0 |